Skip to main content

4.6M Filipinos to benefit from new anti-anginal drug





About 4.6 million Filipinos suffering from chronic stable angina are expected to benefit from a new drug that was introduced at the Philippine Heart Association Annual Convention at the EDSA Shangri-La Manila on Thursday, May 28, 2015.

The Menarini Group, a leading Italian pharmaceutical company known worldwide for its innovative products, recently signed an exclusive long-term agreement with Gilead Sciences, Inc. to launch a new anti-anginal agent, in 140 countries, including the Philippines.

A. Menarini Philippines, Inc. said the novel drug is designed to help millions of Filipinos with stable angina pectoris whose symptoms have not been controlled by first-line and second-line therapy agents like beta blockers and/or calcium antagonists.

The World Health Organization1 has stated that cardiovascular diseases (CVDs) remain the No. 1 cause of death worldwide. In 2008 alone, about 17.3 million died from CVDs, representing 30% of global deaths.

WHO added that over 80% of CVD deaths take place in low- and middle-income countries, and occurs in both men and women. To make matters worse, the New England Journal of Medicine2 added that at 12 months of follow-up, 59% of patients on medical therapy still had uncontrolled angina.

In the Philippines, CVD is a leading cause of mortality and 90% of the population has one or more of the six prevalent risk factors of the disease. These are smoking, physical inactivity, hypertension, hypercholesterolemia, overweight, and obesity.

“We are delighted and honored to further strengthen our long-term partnership with Gilead to help address the needs of angina patients in these new territories, in particular the Asia Pacific region,” said Alberto Giovanni Aleotti, vice president of the Menarini Group.

Menarini is an international pharmaceutical company with over 16,000 employees worldwide in more than 100 countries in Europe, Asia, Latin America, Africa, and the Middle East, and has a 2012 turnover of over €3 billion. It ranks 17th in Europe and 34th in the world, according to the IMS World Review 2012.

The Group has 14 manufacturing sites located in Italy and abroad where over 545 million packages yearly are produced and distributed throughout the five continents, ensuring the health of patients all over the world. For more information, visit http://www.menarini.com/

References:
1.      Global status report on non-communicable diseases 2010. Geneva, World Health   Organization, 2011
2.       N Engl J Med 2007; 356:1503-1516 April 12, 2007

Press Release
 
Labels:

Comments

Post a Comment

Popular posts from this blog

Effective Weight Management with LesoFat and LesoCarb

Successful weight loss takes programming, not willpower. -Phil McGraw Losing weight and maintaining normal weight can be a challenge for many. For most people, the desire to look fit is there but in reality the actions that should be considered are too hard to follow. Looking good by having to lose body fat and weight is just of part of being healthy but the major goal should be focused on having an overall healthy body.    It's possible to get back in shape with proper nutrition, exercise and good supplements for fat loss like LESOFAT and LESOCARB. (photo credit Nutrition Authority) Numerous research studies pointed out that obesity or being overweight is directly linked to many debilitating diseases. People who are obese are prone to diabetes, high blood pressure, heart diseases, high cholesterol levels, arthritis, stroke and even cancer.  What is obesity? Obesity is considered a medical condition wherein the accumulated body fat can h...
Post a Comment
Read more

Transforming Lives: The Impact of SM Group's KSK Program on Filipino Farmers

  Farming futures Jayson and Juanito proudly showcase a selection of produce at the SM City Clark’s Weekend Market. While modern agricultural techniques boost yields for some, there remains a number of Filipino farmers who struggle to keep pace. These experienced hands find themselves falling behind in a market demanding higher production, clinging to familiar yet often inefficient methods passed down through generations. One farmer from Pampanga, Jayson Garcia, sought to disrupt this prevailing narrative in his family. He knew that he had to chart a new course forward for his farm and innovate to remain competitive within the rapidly evolving landscape of modern agriculture. “Noon, mahirap ang magtanim,” he recalled their life before joining SM Foundation’s Kabalikat sa Kabuhayan. “Para bang tsambahan, basta pag itinanim mo ‘yan, hintayin mo na lang mamunga. Mas mahirap pa lalo kapag nagkaroon ng kalamidad,” he added.  SM Foundation’s training program focused on high-value cr...
Post a Comment
Read more

CDA Empowers Cooperatives Through SM Supermalls’ Weekend Market

  Cooperative Development Authority (CDA) and SM Supermalls have officially sealed a strategic partnership through a Memorandum of Agreement (MOA) signing held on Monday, July 1, 2025, at the SM Supermalls Headquarters in Pasay City. The agreement marks the beginning of a joint effort to empower Filipino cooperatives by giving them access to high-foot-traffic mall spaces through the SM Weekend Market — a platform dedicated to showcasing local products, homegrown talent, and Filipino entrepreneurship. L-R: Royston A. Cabunag, Assistant Vice President and Lead for MSME and Job Fairs, Engr. Junias M. Eusebio, Vice President for Mall Operations of SM Supermalls formalized partnership through a MOA signing with CDA Chairperson Usec. Alexander B. Raquepo and CDA Administrator Asec. Santiago S. Lim, that aims to empower Filipino cooperatives through the SM Weekend Market initiative. The MOA was signed by Undersecretary Alexander B. Raquepo, CDA Chairperson, and Engr. Junias M. Eusebio, Vi...
Post a Comment
Read more